We are currently upgrading our print fulfillment systems. Print book orders placed between Sept 22 and Oct 9 will be delayed. Delivery of these orders will start on Oct 10, with purchases being fulfilled in the order received. Buy the Print and get eBook immediately for FREE. Use Code BOGO. Or save up to 40% on all orders with code: DELTA. Exclusions apply. Click here for terms and conditions.
»
Handbook of Neuroemergency Clinical Trials
 
 

Handbook of Neuroemergency Clinical Trials, 1st Edition

 
Handbook of Neuroemergency Clinical Trials, 1st Edition,Wayne Alves,Brett Skolnick,ISBN9780126480825
 
 
 

Alves   &   Skolnick   

Academic Press

9780126480825

9780080454351

360

260 X 184

Summarizes the state-of-the-practice of clinical trials in neurological emergencies.

Print Book + eBook

USD 288.00
USD 480.00

Buy both together and save 40%

Print Book

Hardcover

In Stock

Estimated Delivery Time
USD 245.00

eBook
eBook Overview

VST format:

DRM Free included formats: PDF

USD 235.00
Add to Cart
 
 

Key Features

* Presents new perspectives on acute neuroemergency clinical trials
* Includes insights from clinical pharmacology and industry perspectives
* Discusses historical lessons learned from early and recent trials in acute neuroscience populations

Description

During the 1990’s, scientific advances in understanding the mechanisms and pathophysiology of acute central nervous system injury were offset by a history of disappointing results from Phase III clinical trials of novel neuroprotective drugs. Numerous novel compounds were “tested,” and seemingly fell by the wayside. This book is intended to focus on novel therapies and the unique challenges their intended targets pose for the design and analysis of clinical trials. The authors explore the issues facing research in this area and the strategies that might lead to future success in this critical area of unmet medical need. It represents a compendium of information gained from over 20 years of clinical trial experience in areas of acute neurology and neurosurgery. From the knowledge of clinical assessment using standardized tools, to the intricate design of difficult hyper-acute neuroemergencies trials, the reader will benefit from the authors’ perspectives.

Readership

Researchers involved with the design of neuroemergency clinical trials, at research labs in universities, hospitals, major pharmaceutical (e.g., Astra Zeneca, GSK), biotechnology companies involved in these clinical areas.

Wayne Alves

Affiliations and Expertise

Valeant Pharmaceuticals Inc., Costa Mesa, CA, USA

Brett Skolnick

Affiliations and Expertise

Novo Nordisk Pharmaceuticals, Inc., Princeton, NJ, USA

Handbook of Neuroemergency Clinical Trials, 1st Edition

STROKE AND TRAUMA
1. Acute Ischemic Stroke (Christopher Bladin, Stephen Davis)
2. Subarachnoid Hemorrhage (Nader Pouratian, Aaron S. Dumont, Neal F. Kassell)
3. Spontaneous Intracerebral Hemorrhage (Michael D. Hill)
4. Traumatic Brain Injury (Lawrence F. Marshall, Wayne Alves)

CENTRAL NERVOUS SYSTEM EMERGENCIES
5. Acute Seizures and Status Epilepticus (Susan T. Herman)
6. Clinical Trials in Neuro-opthamology (Laura Balcer, Madhura A. Tamhankar)
7. Brain Resuscitation (Edwin M. Nemoto)
8. Clinical Trials in Brain Injury after Cardiac Arrest (Romergryko G. Geocadin, Daniel F. Hanley)

SPECIAL ISSUES IN ACUTE NEUROSCIENCE CLINICAL TRIALS
9. Efficient Dose-Response Finding Strategies for Acute Neuroemergency Treatments (Tom Parke, Michael Krams, Peter Mueller, Don Berry)
10. Biostatistical Issues in Neuroemergency Clinical Trials (Wayne M. Alves)
11. Data and Safety Monitoring Boards (Brett Skolnick)
12. Role of the Project Medical Officer (Joseph Kwentus)
13. Ethical Considerations (Wayne Alves)

PERSPECTIVES ON NEUROEMERGENCY DRUG DEVELOPMENT
14. Industry Perspective on Drug Development (Thomas C. Wessel, Chris Gallen)
15. Regulatory Considerations (Lisa Travis)
 
 
Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ